STEPHANIE MORENO: Open Payments
NPI 1871299263 · GEORGETOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 62 payments from 13 companies in 2025. Trend: 2023 $184 · 2024 $728 · 2025 $1,120
Food & beverage: $1,116Education: $5
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $212 |
| ABBVIE INC. | 10 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $169 |
| Ferring Pharmaceuticals Inc. | 11 | $141 |
| UROGEN PHARMA, INC. | 3 | $68 |
| Endo USA, Inc. | 3 | $66 |
| Janssen Biotech, Inc. | 3 | $56 |
| Olympus America Inc. | 1 | $45 |
| PFIZER INC. | 2 | $41 |
| IMMUNITYBIO, INC. | 2 | $41 |
Products named: BOTOX, Nubeqa, ADSTILADRIN, GEMTESA, ORGOVYX, Xtandi, AVEED, iTIND System.
Industry payments across TX — which companies pay providers there.
